Dr. Jyotsna Fuloria
Claim this profileUniversity Medical Center New Orleans
Affiliated Hospitals
University Medical Center New Orleans
Ochsner Health System
Clinical Trials Jyotsna Fuloria is currently running
HPV Vaccine
for HIV/AIDS
The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adults with well-controlled HIV infection. The secondary objectives of the study are to observe short term clinical outcomes of prevalent HPV genotype-specific anogenital infections in adults living with HIV who complete the three-dose Gardasil-9 vaccine series, and to determine the protection afforded by Gardasil vaccine over time in previously vaccinated adults living with HIV. The clinical hypothesis is that adults with virologically controlled HIV mount a serum antibody response to the nonavalent HPV vaccine that is comparable to HIV negative counterparts. We also postulate that HPV vaccination will provide short-term clinical benefit against HPV infections and disease associated with vaccine genotypes and continuing protection against vaccine genotypes of HPV over time.
Recruiting
4 awards
Phase 4
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting
1 award
Phase 2
3 criteria
More about Jyotsna Fuloria
Clinical Trial Related
3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jyotsna Fuloria has experience with
- Placebo
- GBT021601
- APOL1 Status
- SHP655
- Capecitabine
- Ivaltinostat
Breakdown of trials Jyotsna Fuloria has run
Sickle Cell Disease
Chronic Kidney Disease
High Blood Pressure
Kidney Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jyotsna Fuloria specialize in?
Jyotsna Fuloria focuses on Sickle Cell Disease and Chronic Kidney Disease. In particular, much of their work with Sickle Cell Disease has involved treating patients, or patients who are undergoing treatment.
Is Jyotsna Fuloria currently recruiting for clinical trials?
Yes, Jyotsna Fuloria is currently recruiting for 2 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Jyotsna Fuloria has studied deeply?
Yes, Jyotsna Fuloria has studied treatments such as Placebo, GBT021601, APOL1 status.
What is the best way to schedule an appointment with Jyotsna Fuloria?
Apply for one of the trials that Jyotsna Fuloria is conducting.
What is the office address of Jyotsna Fuloria?
The office of Jyotsna Fuloria is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.